Anonymous
Guest
Anonymous
Guest
Is it in the board's interest to have the company wrapped up in a year rather than two?
I presume the Feds are done by then and so legal fees have all been paid.
Can they stall the shareholder suits and avoid embarrassing depositions for a full year?
Will they have to do something else to bring it down in 6 months?
What can they do that looks like they are "responding to the market", but really just accelerates bankruptcy... take a $100-200M writedown, stop making as much product, get rid of the sales force, but they've done that already!, so what else? Bad news earnings calls? done that.. Inappropriate labeling of the product so it's not used at the best time, nope, already done..... Screw up the clinical trial so the product doesn't look as good,.... keep thinking they are ahead of you..... Get a CEO who has run another pharma with product into the ground, ... ok, you're thinking even more like them now, but keep going, they need more.... Make everyone think that you are moving so they won't take your job offer in sales.... yep....I suppose they could "get" a viral infection in the production plants. What do you think, before or after the next EC? No, members of the board go to lawyers' offices, not the plants, and they don't know anything about viruses and immunology, wait, one of them does! Is he scheduled to visit them? but, hmmm, what else? They could have monthly instead of quarterly Earnings Calls, those always halve the share price,.... how do you have a cure for cancer and become bankrupt faster, surely that's a challenge D'Enron can continue to meet.
Inquiring minds want to know.
I presume the Feds are done by then and so legal fees have all been paid.
Can they stall the shareholder suits and avoid embarrassing depositions for a full year?
Will they have to do something else to bring it down in 6 months?
What can they do that looks like they are "responding to the market", but really just accelerates bankruptcy... take a $100-200M writedown, stop making as much product, get rid of the sales force, but they've done that already!, so what else? Bad news earnings calls? done that.. Inappropriate labeling of the product so it's not used at the best time, nope, already done..... Screw up the clinical trial so the product doesn't look as good,.... keep thinking they are ahead of you..... Get a CEO who has run another pharma with product into the ground, ... ok, you're thinking even more like them now, but keep going, they need more.... Make everyone think that you are moving so they won't take your job offer in sales.... yep....I suppose they could "get" a viral infection in the production plants. What do you think, before or after the next EC? No, members of the board go to lawyers' offices, not the plants, and they don't know anything about viruses and immunology, wait, one of them does! Is he scheduled to visit them? but, hmmm, what else? They could have monthly instead of quarterly Earnings Calls, those always halve the share price,.... how do you have a cure for cancer and become bankrupt faster, surely that's a challenge D'Enron can continue to meet.
Inquiring minds want to know.